Cell signaling by reactive nitrogen and oxygen species in atherosclerosis

Free Radical Biology and Medicine

Volumn 28, Issue 12, 2000, Pages 1780-1794

  Patel, Rakesh P ^a   Moellering, Douglas ^a   Murphy Ullrich, Joanne ^a   Jo, Hanjoong ^a   Beckman, Joseph S ^a,b   Darley Usmar, Victor M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antioxidant; Atherosclerosis; Free radical; Low density lipoprotein; Nitration; Nitric oxide; Peroxynitrite; Reactive nitrogen species; Seeding peroxides; Shear stress

Indexed keywords

ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; CALMODULIN; CAVEOLIN; CHOLESTEROL; GUANYLATE CYCLASE; HEMOGLOBIN; HYDROGEN PEROXIDE; HYPOCHLORITE; LIPID; LOW DENSITY LIPOPROTEIN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN; OXYGEN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; TYROSINE;

APOPTOSIS; ATHEROSCLEROSIS; HUMAN; NITRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHEAR STRESS;

EID: 0034659143     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00235-5     Document Type: Article

References (159)

1. Ross R. Atherosclerosis - an inflammatory. N. Engl. J. Med. 340:1999;115-126.
2. Navab M., Fogelman A.M., Berliner J.A., Territo M.C., Demer L.L., Frank J.S., Watson A.D., Edwards P.A., Lusis A.J. Pathogenesis of atherosclerosis. Am. J. Cardiol. 76:1995;18C-23C.
3. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
4. Darley-Usmar V.M., Hassall D.G. The role of macrophages and the modification of LDL in the pathogenesis of atherosclerosis. Curtis M.J. Immunopharmacology of the heart. 1993;43-51 Academic Press, London.
5. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
6. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
7. Parthasarathy S., Printz D.J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6:1986;505-510.
8. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
9. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3:1990;77-92.
10. Rubbo H., Darley-Usmar V., Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9:1996;809-820.
11. Jurgens G., Ashy A., Esterbauer H. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochem. J. 265:1990;605-608.
12. Mowri H., Ohkuma S., Takano T. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions. Biochim. Biophys. Acta. 963:1988;208-214.
13. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssonen K., Palinski W., Witztum J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
14. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler. 375:1994;81-88.
15. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield E.N., Parums D.V., Yacoub M.H., Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75:1996;77-85.
16. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:1997;1433-1436.
17. Hazen S.L. Heinecke, J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075-2081.
18. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
19. Carew T.E., Schwenke D.C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit . Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
20. Bjorkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:1991;15-22.
21. Tangirala R.K., Casanada F., Miller E., Witztum J.L., Steinberg D., Palinski W. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 15:1995;1625-1630.
22. Cynshi O., Kawabe Y., Suzuki T., Takashima Y., Kaise H., Nakamura M., Ohba Y., Kato Y., Tamura K., Hayasaka A., Higashida A., Sakaguchi H., Takeya M., Takahashi K., Inoue K., Noguchi N., Niki E., Kodama T. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc. Natl. Acad. Sci. USA. 95:1998;10123-10128.
23. Chisolm G.M. Antioxidants and atherosclerosis a current assessment . Clin. Cardiol. 14:1991;I25-I30.
24. Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 19:1999;1708-1718.
25. Witting P., Pettersson K., Ostlund-Lindqvist A.M., Westerlund C., Wagberg M., Stocker R. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 104:1999;213-220.
26. Darley-Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 17:1992;9-20.
27. Hogg N., Darley-Usmar V.M., Graham A., Moncada S. Peroxynitrite and atherosclerosis. Biochem. Soc. Trans. 21:1993;358-362.
28. Kalyanaraman B., Darley-Usmar V., Struck A., Hogg N., Parthasarathy S. Role of apolipoprotein B-derived radical and alpha-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein. J. Lipid Res. 36:1995;1037-1045.
29. Ziouzenkova O., Asatryan L., Akmal M., Tetta C., Wratten M.L., Loseto-Wich G., Jurgens G., Heinecke J., Sevanian A. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J. Biol. Chem. 274:1999;18916-18924.
30. Lenz M.L., Hughes H., Mitchell J.R., Via D.P., Guyton J.R., Taylor A.A., Gotto A.M.J., Smith C.V. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J. Lipid Res. 31:1990;1043-1050.
31. Ball R.Y., Stowers E.C., Burton J.H., Cary N.R., Skepper J.N., Mitchinson M.J. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 114:1995;45-54.
32. Lancaster J.R. Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. USA. 91:1994;8137-8141.
33. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide physiology, pathophysiology, and pharmacology . Pharmacol. Rev. 43:1991;109-142.
34. Darley-Usmar V.M., White R. Disruption of vascular signalling by the reaction of nitric oxide with superoxide implications for cardiovascular disease . Exp. Physiol. 82:1997;305-316.
35. McAndrew J., Patel R.P., Jo H., Cornwell T., Lincoln T., Moellering D., White C.R., Matalon S., Darley-Usmar V. The interplay of nitric oxide and peroxynitrite with signal transduction pathways implications for disease . Semin. Perinatol. 21:1997;351-366.
36. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S-nitrosohaemoglobin a dynamic activity of blood involved in vascular . Nature. 380:1996;221-226.
37. Patel R.P., Hogg N., Spencer N.Y., Kalyanaraman B., Matalon S., Darley-Usmar V.M. Biochemical characterization of human S-nitrosohemoglobin. Effects on oxygen binding and transnitrosation. J. Biol. Chem. 274:1999;15487-15492.
38. Gow A.J., Stamler J.S. Reactions between nitric oxide haemoglobin under physiological conditions. Nature. 391:1998;169-173.
39. Lincoln T.M., Cornwell T.L. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328-338.
40. Minor R.L., Myers P.R., Guerra R., Bates J.N., Harrison D.G. Diet induced Atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86:1990;2109-2116.
41. Mugge A., Elwell J.H., Peterson T.E., Hofmeyer T.G., Heistad D. D; Harrison, D. G. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69:1991;1293-1300.
42. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;1044-1048.
43. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91:1993;2546-2551.
44. Naruse K., Shimizu K., Muramatsu M., Toki Y., Miyazaki Y., Okumura K., Hashimoto H., Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler. Thromb. 14:1994;746-752.
45. Cooke J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1992;1168-1172.
46. Cayatte A.J., Palacino J.J., Horten K., Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14:1994;753-759.
47. Hogg N., Kalyanaraman B., Joseph J., Struck A., Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 334:1993;170-174.
48. O'Donnell V.B., Eiserich J.P., Chumley P.H., Jablonsky M.J., Krishna N.R., Kirk M., Barnes S., Darley-Usmar V.M., Freeman B.A. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 12:1999;83-92.
49. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, peroxynitrite the good, the bad, and ugly . Am. J. Physiol. 271:1996;C1424-C1437.
50. Vliet D.V., Eiserich J.P., Halliwell B., Cross C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272:1997;7617-7625.
51. Patel R.P., Diczfalusy U., Dzeletovic S., Wilson M.T., Darley-Usmar V.M. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid Res. 37:1996;2361-2371.
52. Moore K.P., Darley-Usmar V., Morrow J., Roberts L.J. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ. Res. 77:1995;335-341.
53. Candipan R.C., Wang B.Y., Buitrago R., Tsao P.S., Cooke J.P. Regression or progression. Dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol. 16:1996;44-50.
54. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide . Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
55. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103:1999;1547-1560.
56. Patel R.P. Darley-Usmar, V. M. Using peroxynitrite as oxidant with low-density lipoprotein. Methods Enzymol. 269:1996;375-384.
57. Pannala A.S., Rice-Evans C., Sampson J., Singh S. Interaction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Lett. 423:1998;297-301.
58. Go Y.-M., Patel R.P., Maland M.C., Park H., Beckman J.S., Darley-Usmar V.M., Jo H. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of cJun N-terminal kinase in endothelial cells. Am. J. Physiol. 277:1999;H1647-H1653.
59. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
60. Campbell G.R., Chamley-Campbell J.H. Smooth muscle phenotypic modulation role in atherogenesis . Med. Hypotheses. 7:1981;729-735.
61. Lincoln T.M., Cornwell T.L., Komalavilas P., Boerth N. Cyclic GMP-dependent protein kinase in nitric oxide signaling. Methods Enzymol. 269:1996;149-166.
62. Kissner, R.; Nauser, T.; Bugnon, P.; Lye, P. G.; Koppenol, W. H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis [published erratum appears in Chem Res Toxicol 1998 May;11(5):557]. Chem. Res. Toxicol. 10:1285-1292; 1997.
63. Kissner, R.; Nauser, T.; Bugnon, P.; Lye, P. G.; Koppenol, W. H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis [published erratum appears in Chem Res Toxicol 1998 May;11(5):557]. Chem. Res. Toxicol. 10:1285-1292; 1997.
64. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia enhancement by angiotensin II . Proc. Natl. Acad. Sci. USA. 94:1997;14483-14488.
65. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
66. Kuchan M.J., Jo H., Frangos J.A. Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am. J. Physiol. 267:1994;C753-C758.
67. De Keulenaer G.W., Chappell D.C., Ishizaka N., Nerem R.M., Alexander R.W., Griendling K.K. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state role of a superoxide-producing NADH oxidase . Circ. Res. 82:1998;1094-1101.
68. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1996;1916-1923.
69. Pritchard K.A.J., Groszek L., Smalley D.M., Sessa W.C., Wu M., Villalon P., Wolin M.S., Stemerman M.B. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ. Res. 77:1995;510-518.
70. Amaya Y., Yamazaki K., Sato M., Noda K., Nishino T., Nishino N. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J. Biol. Chem. 265:1990;14170-14175.
71. White C.R., Darley-Usmar V., Berrington W.R., McAdams M., Gore J.Z., Thompson J.A., Parks D.A., Tarpey M.M., Freeman B.A. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA. 93:1996;8745-8749.
72. Vasquez-Vivar, J.; Kalyanaraman, B.; Martasek, P.; Hogg, N.; Masters, B. S.; Karoui, Tordo, P.; Pritchard, K. A. Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA 95:9220-9225; 1998.
73. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic. Biol. Med. 20:1996;957-965.
74. Fukai T., Galis Z.S., Meng X.P., Parthasarathy S., Harrison D.G. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J. Clin. Invest. 101:1998;2101-2111.
75. Rubbo, H.; Radi, R.; Trujillo, M.; Telleri, R.; Kalyanaraman, B.; Barnes, S.; Kirk, Freeman, B. A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269:26066-26075; 1994.
76. Steinberg D. At last, direct evidence that lipoxygenases play a role in atherogenesis. J. Clin. Invest. 103:1999;1487-1488.
77. Ramasamy S., Parthasarathy S., Harrison D.G. Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J. Lipid Res. 39:1998;268-276.
78. O'Donnell V.B., Taylor K.B., Parthasarathy S., Kuhn H., Koesling D., Friebe A., Bloodsworth A., Darley-Usmar V.M., Freeman B.A. 15-Lipoxygenase catalytically consumes nitric oxide and impairs activation of guanylate cyclase. J. Biol. Chem. 274:1999;20083-20091.
79. Goodwin D.C., Landino L.M., Marnett L.J. Reactions of prostaglandin endoperoxide synthase with nitric oxide and peroxynitrite. Drug Metab. Rev. 31:1999;273-294.
80. Zou M., Yesilkaya A., Ullrich V. Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metab. Rev. 31:1999;343-349.
81. Zou M., Jendral M., Ullrich V. Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase. Br. J. Pharmacol. 126:1999;1283-1292.
82. Stamler J.S. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr. Top. Microbiol. Immunol. 196:1995;19-36.
83. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide in its redox-activated forms. Science. 258:1992;1898-1902.
84. Eiserich J.P., Patel R.P., O'Donnell V.B. Pathophysiology of nitric oxide and related species free radical reactions and modification of biomolecules . Mol. Aspects Med. 19:1998;221-357.
85. Butler A.R., Rhodes P. Chemistry, analysis, and biological roles of S-nitrosothiols. Anal. Biochem. 249:1997;1-9.
86. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:1995;7017-7020.
87. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A. J, Stamler, J. S. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
88. Rossig, L.; Fichtlscherer, B.; Breitschopf, K.; Haendeler, J.; Zeiher, A. M.; Mulsch, Dimmeler, S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J. Biol. Chem. 274:6823-6826; 1999.
89. Zech B., Wilm M., van Eldik R., Brune B. Mass spectrometric analysis of nitric oxide-modified caspase-3. J. Biol. Chem. 274:1999;20931-20936.
90. Klatt P., Molina E.P., Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J. Biol. Chem. 274:1999;15857-15864.
91. Dimmeler S., Haendeler J., Rippmann V., Nehls M., Zeiher A.M. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 399:1996;71-74.
92. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271:1996;11317-11324.
93. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A.J., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-68.
94. Denninger J.W., Marletta M.A. Guanylate cyclase the ·NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411:1999;334-350.
95. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
96. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
97. Eiserich J.P., Cross C.E., Jones A.D., Halliwell B., Van D., Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J. Biol. Chem. 271:1996;19199-19208.
98. Kong S.K., Yim M.B., Stadtman E.R., Chock P.B. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide . Proc. Natl. Acad. Sci. USA. 93:1996;3377-3382.
99. Gow A.J., Duran D., Malcolm S., Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 385:1996;63-66.
100. Takakura K., Beckman J.S., MacMillan-Crow L.A., Crow J.C. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1, CD45 and LAR by peroxynitrite. Arch. Biochem. Biophys. 369:1999;197-207.
101. Stamler J.S., Toone E.J., Lipton S.A., Sucher N.J. (S)NO signals translocation, regulation, and a consensus motif . Neuron. 18:1997;691-696.
102. Stamler J.S. Redox signaling nitrosylation and related target interactions of nitric oxide . Cell. 78:1994;931-936.
103. Gow A.J., Luchsinger B.P., Pawloski J.R., Singel D.J., Stamler J.S. The oxyhemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. USA. 96:1999;9027-9032.
104. Wink D.A., Nims R.W., Darbyshire J.F., Christodoulou D., Hanbauer I., Cox G.W., Laval F., Laval J., Cook J.A., Krishna M.C. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem. Res. Toxicol. 7:1994;519-525.
105. Kharitonov V.G., Sundquist A.R., Sharma V.S. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem. 270:1995;28158-28164.
106. Marley R., Feelisch M., Holt S., Moore K. A chemiluminescense based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 32:1999;1-9.
107. Liu X., Miller M.S., Joshi M.S., Thomas D.D., Lancaster J.R. Jr. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA. 95:1998;2175-2179.
108. Liu X., Miller M.J., Joshi M.S., Sadowska-Krowicka H., Clark D.A., Lancaster J.R. Jr. Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273:1998;18709-18713.
109. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
110. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
111. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233:1994;229-240.
112. Moro M.A., Darley-Usmar V.M., Goodwin D.A., Read N.G., Zamora-Pino R., Feelisch M., Radomski M.W., Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA. 91:1994;6702-6706.
113. Mayer B., Schrammel A., Klatt P., Koesling D., Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J. Biol. Chem. 270:1995;17355-17360.
114. Moro M.A., Darley-Usmar V.M., Lizasoain I., Su Y., Knowles R.G., Radomski M.W., Moncada S. The formation of nitric oxide donors from peroxynitrite. Br. J. Pharmacol. 116:1995;1999-2004.
115. White C.R., Moellering D., Patel R.P., Kirk M., Barnes S., Darley-Usmar V.M. Formation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol. Biochem. J. 328:1997;517-524.
116. Mayer B., Pfeiffer S., Schrammel A., Koesling D., Schmidt K., Brunner F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 273:1998;3264-3270.
117. van der Vliet A., Hoen P.A., Wong P.S., Bast A., Cross C.E. Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J. Biol. Chem. 273:1998;30255-30262.
118. Balazy M., Kaminski P.M., Mao K., Tan J., Wolin M.S. S-Nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J. Biol. Chem. 273:1998;32009-32015.
119. Arnelle D.R., Stamler J.S. NO+, NO, and NO- donation by S-nitrosothiols implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation . Arch. Biochem. Biophys. 318:1995;279-285.
120. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA. 93:1996;11853-11858.
121. Zou M.H., Leist M., Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J. Pathol. 154:1999;1359-1365.
122. Crow J.P., Ye Y.Z., Strong M., Kirk M., Barnes S., Beckman J.S. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69:1997;1945-1953.
123. Pfeiffer S., Mayer B. Lack of tyrosine nitration by peroxynitrite generated at physiological pH. J. Biol. Chem. 273:1998;27280-27285.
124. Patel R.P., McAndrew J., Sellak H., White C.R., Jo H., Freeman B.A., Darley-Usmar V.M. Biological aspects of reactive nitrogen species. Biochim. Biophys. Acta. 1411:1999;385-400.
125. Goss S.P.A., Singh R.J., Hogg H., Kalyanaraman B. Reactions of NO, NO2, peroxynitrite in membranes physiological implications . Free Radic. Res. 31:1999;597-608.
126. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9:1996;836-844.
127. Goss S.P., Hogg N., Kalyanaraman B. The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite. Arch. Biochem. Biophys. 363:1999;333-340.
128. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., Vander Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391:1998;393-397.
129. Patel R.P., Darley-Usmar V.M. Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein. Free Radic. Res. 30:1999;1-9.
130. Bowry V.W., Ingold K.U., Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288:1992;341-344.
131. Banerjee M., Kang K.H., Morrow J.D., Roberts L.J., Newman J.H. Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am. J. Physiol. 263:1992;H660-H663.
132. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
133. Yamasaki K., Edington H.D., McClosky C., Tzeng E., Lizonova A., Kovesdi I., Steed D.L., Billiar T.R. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 101:1998;967-971.
134. Shin J.T., Barbeito L., MacMillan-Crow L.A., Beckman J.S., Thompson J.A. Acidic fibroblast growth factor enhances peroxynitrite-induced apoptosis in primary murine fibroblasts. Arch. Biochem. Biophys. 335:1996;32-41.
135. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:1990;597-641.
136. Roberts A.B. Transforming growth factor-β activity and efficacy in animal models of wound healing . Wound Rep. Reg. 3:1995;408-418.
137. Lawrence D.A. Transforming growth factor-beta:a general review. Eur. Cytokine Netw. 7:1996;363-374.
138. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., Rifkin D.B. Latent transforming growth factor-beta structural features and mechanisms of activation . Kidney Int. 51:1997;1376-1382.
139. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Laoler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-beta 1 in vivo. Cell. 93:1998;1159-1170.
140. Barcellos-Hoff M.H., Dix T.A. Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10:1996;1077-1083.
141. Barcellos-Hoff M.H., Derynck R., Tsang M.L., Weatherbee J.A. Transforming growth factor-beta activation in irradiated murine mammary gland. J. Clin. Invest. 93:1994;892-899.
142. Thannickal V.J., Fanburg B.L. Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J. Biol. Chem. 270:1995;30334-30338.
143. Ohba M., Shibanuma M., Kuroki T., Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126:1994;1079-1088.
144. Tsao P.S., Buitrago R., Chan J.R., Cooke J.P. Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation. 94:1996;1682-1689.
145. Stuehr D.J. Mammalian nitric oxide synthases. Biochim. Biophys. Acta. 1411:1999;217-230.
146. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. USA. 96:1999;8757-8761.
147. Kanai A.J., Strauss H.C., Truskey G.A., Crews A.L., Grunfeld S., Malinski T. Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ. Res. 77:1995;284-293.
148. Ku D.N., Giddens D.P., Zarins C.K., Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 5:1985;293-302.
149. Zarins C.K., Giddens D.P., Bharadvaj B.K., Sottiurai V.S., Mabon R.F., Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ. Res. 53:1983;502-514.
150. Kraiss L.W., Kirkman T.R., Kohler T.R., Zierler B., Clowes A.W. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler. Thromb. 11:1991;1844-1852.
151. Langille B.L., O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 231:1986;405-407.
152. Topper J.N., Cai J., Falb D., Gimbrone M.A. Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress . Proc. Natl. Acad. Sci. USA. 93:1996;10417-10422.
153. Moellering D., McAndrew J., Patel R.P., Cornwell T., Lincoln T.M., Cao X., Messina J.L., Forman H.J., Jo H., Darley-Usmar V.M. Nitric oxide-dependent induction of glutathione synthesis through increased expression of gamma-glutamylcysteine synthetase. Arch. Biochem. Biophys. 358:1998;74-82.
154. Moellering D., McAndrew J., Patel R.P., Forman H.J., Mulcahy R.T., Jo H., Darley-Usmar V.M. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase . FEBS Lett. 448:1999;292-296.
155. Li H., Marshall Z.M., Whorton A.R. Stimulation of cystine uptake by nitric oxide regulation of endothelial cell glutathione levels . Am. J. Physiol. 276:1999;C803-C811.
156. Nossuli T.O., Hayward R., Jensen D., Scalia R., Lefer A.M. Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am. J. Physiol. 275:1998;H509-H519.
157. Feron O., Saldana F., Michel J.B., Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 273:1998;3125-3128.
158. Michel J.B., Feron O., Sase K., Prabhakar P., Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 272:1997;25907-25912.
159. Feron O., Dessy C., Moniotte S., Desager J.P., Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 103:1999;897-905.